ULTA BEAUTY INC (ULTA) Forecast, Price Target & Analyst Ratings
NASDAQ:ULTA • US90384S3031
646.34 USD
-7.3 (-1.12%)
At close: Mar 6, 2026
638.28 USD
-8.06 (-1.25%)
After Hours: 3/6/2026, 8:00:02 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ULTA BEAUTY INC (ULTA).
Forecast Snapshot
Consensus Price Target
$688.12
+ 6.46% Upside
Next Earnings Forecast
Release DateMay 27, 2026
PeriodQ4 / 2026
EPS Estimate$8.18
Revenue Estimate3.892B
ChartMill Buy Consensus
76.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$688.12
Upside
+ 6.46%
From current price of $646.34 to mean target of $688.12, Based on 35 analyst forecasts
Low
$454.50
Median
$698.70
High
$829.50
Price Target Revisions
1 Month
5.76%
3 Months
16.50%
Price Target Summary
35 analysts have analysed ULTA and the average price target is 688.13 USD. This implies a price increase of 6.46% is expected in the next year compared to the current price of 646.34.
The average price target has been revised upward by 16.5% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
76.00%
ULTA was analyzed by 35 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about ULTA.
In the previous month the buy percentage consensus was at a similar level.
ULTA was analyzed by 35 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-21 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-21 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2026-01-20 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2026-01-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-01-08 | B of A Securities | Maintains | Neutral -> Neutral |
| 2026-01-07 | UBS | Maintains | Buy -> Buy |
| 2026-01-02 | Argus Research | Maintains | Buy -> Buy |
| 2025-12-10 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-12-08 | TD Cowen | Upgrade | Hold -> Buy |
| 2025-12-08 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-05 | Guggenheim | Reiterate | Neutral -> Neutral |
| 2025-12-05 | DA Davidson | Maintains | Buy -> Buy |
| 2025-12-05 | UBS | Maintains | Buy -> Buy |
| 2025-12-05 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-12-05 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2025-12-05 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-12-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-12-05 | Baird | Maintains | Outperform -> Outperform |
| 2025-12-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-12-05 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-12-01 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2025-12-01 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-17 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2025-10-16 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-10-10 | Canaccord Genuity | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 27, 2026
PeriodQ4 / 2026
EPS Estimate$8.18
Revenue Estimate3.892B
Revenue Q2Q11.59%
EPS Q2Q-3.29%
Number of Analysts27
Next Earnings Revisions
Revenue (1 Month)
0.49%
Revenue (3 Months)
2.61%
EPS (1 Month)
0.64%
EPS (3 Months)
5.88%
Next Earnings Summary
ULTA is expected to report earnings on 5/27/2026. The consensus EPS estimate for the next earnings is 8.18 USD and the consensus revenue estimate is 3.89B USD.
The next earnings revenue estimate has been revised upward by 2.61% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.209B 18.28% | 11.207B 9.78% | 11.296B 0.79% | 12.58B 11.37% | 13.344B 6.07% | 13.984B 4.80% | 14.903B 6.57% | 15.581B 4.55% | 16.505B 5.93% | 17.398B 5.41% | 18.265B 4.98% | 19.159B 4.89% | |
| EBITDA YoY % growth | 1.88B 20.11% | 1.922B 2.21% | 1.832B -4.68% | 1.859B 1.47% | 1.988B 6.94% | 2.078B 4.53% | 2.215B 6.59% | 2.332B 5.28% | 2.457B 5.36% | 2.585B 5.21% | 2.715B 5.03% | 2.85B 4.97% | |
| EBIT YoY % growth | 1.639B 26.37% | 1.678B 2.38% | 1.565B -6.74% | 1.556B -0.57% | 1.668B 7.20% | 1.752B 5.04% | 1.843B 5.19% | 1.969B 6.84% | 2.076B 5.43% | 2.167B 4.38% | 2.277B 5.08% | 2.39B 4.96% | |
| Operating Margin | 16.05% | 14.97% | 13.85% | 12.37% | 12.50% | 12.53% | 12.37% | 12.64% | 12.58% | 12.46% | 12.47% | 12.47% | |
| EPS YoY % growth | 24.02 33.59% | 26.05 8.45% | 25.37 -2.61% | 26.02 2.56% | 28.78 10.60% | 31.61 9.84% | 34.69 9.74% | 39.50 13.88% | 43.93 11.21% | 48.48 10.37% | 53.62 10.60% | 58.63 9.34% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 8.18 -3.29% | 7.41 10.30% | 6.45 11.36% | 5.89 14.55% | 8.90 8.72% | 7.70 3.87% | 6.82 5.71% | 5.89 -0.01% | 9.35 5.10% |
| Revenue Q2Q % growth | 3.892B 11.59% | 3.139B 10.20% | 3.047B 9.27% | 3.039B 6.35% | 4.032B 3.60% | 3.212B 2.33% | 3.124B 2.53% | 3.053B 0.46% | 4.147B 2.85% |
| EBITDA Q2Q % growth | 560.18M -28.49% | 515.34M 8.77% | 454.14M -6.95% | 414.08M -21.64% | 585.3M 4.48% | 534.99M 3.81% | 473.79M 4.33% | 402.39M -2.82% | 615.57M 5.17% |
| EBIT Q2Q % growth | 483.2M -6.41% | 435.01M 8.27% | 376.46M 9.17% | 337.2M 8.98% | 492.98M 2.02% | 437.71M 0.62% | 386.3M 2.61% | 356.42M 5.70% | 530.03M 7.52% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
7.60%
EPS Next 5 Year
9.26%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
6.77%
Revenue Next 5 Year
6.28%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
11.23%
EBIT Next 5 Year
9.08%
ULTA BEAUTY INC / ULTA Forecast FAQ
What do analysts expect the price target to be for ULTA BEAUTY INC (ULTA)?
35 analysts have analysed ULTA and the average price target is 688.13 USD. This implies a price increase of 6.46% is expected in the next year compared to the current price of 646.34.
Can you provide the upcoming earnings date for ULTA BEAUTY INC?
ULTA BEAUTY INC (ULTA) will report earnings on 2026-05-27.
Can you provide the consensus estimates for ULTA BEAUTY INC next earnings?
The consensus EPS estimate for the next earnings of ULTA BEAUTY INC (ULTA) is 8.18 USD and the consensus revenue estimate is 3.89B USD.
What is the consensus rating for ULTA stock?
The consensus rating for ULTA BEAUTY INC (ULTA) is 76 / 100 . This indicates that analysts generally have a positive outlook on the stock.